R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 27.

Abstract

In this update, we review the US FDA's updated compendium of real-world evidence (RWE) use in medical device regulatory decisions, a comprehensive scan of RWE utilization in Canadian drug reimbursement submissions, and Institute for Clinical and Economic Review's use of RWE to inform US Medicare drug price negotiations under the Inflation Reduction Act.